Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

High sensitivity troponin T and incident heart failure in older men: British Regional Heart Study.

Welsh P, Papacosta O, Ramsay S, Whincup P, McMurray J, Wannamethee G, Sattar N.

J Card Fail. 2018 Aug 10. pii: S1071-9164(18)30884-4. doi: 10.1016/j.cardfail.2018.08.002. [Epub ahead of print]

PMID:
30103019
2.

Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.

Haig C, Carrick D, Carberry J, Mangion K, Maznyczka A, Wetherall K, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Mordi I, Ahmed N, Teng Yue May V, Ford I, Radjenovic A, Welsh P, Sattar N, Oldroyd KG, Berry C.

JACC Cardiovasc Imaging. 2018 Jul 13. pii: S1936-878X(18)30512-6. doi: 10.1016/j.jcmg.2018.05.022. [Epub ahead of print]

3.

Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction.

Carrick D, Haig C, Maznyczka AM, Carberry J, Mangion K, Ahmed N, Yue May VT, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Mordi I, Ford I, Radjenovic A, Welsh P, Sattar N, Wetherall K, Oldroyd KG, Berry C.

Hypertension. 2018 Jul 16. pii: HYPERTENSIONAHA.117.10786. doi: 10.1161/HYPERTENSIONAHA.117.10786. [Epub ahead of print]

PMID:
30012869
4.

Associations of dietary protein intake with fat free mass and grip strength: cross-sectional study in 146,816 UK Biobank participants.

Celis-Morales CA, Petermann F, Steell L, Anderson J, Welsh P, Mackay DF, Iliodromiti S, Lyall DM, Lean ME, Pell JP, Sattar N, Gill JMR, Gray SR.

Am J Epidemiol. 2018 Jun 29. doi: 10.1093/aje/kwy134. [Epub ahead of print]

PMID:
29961893
5.

Metformin, lipids and atherosclerosis prevention.

Jenkins AJ, Welsh P, Petrie JR.

Curr Opin Lipidol. 2018 Aug;29(4):346-353. doi: 10.1097/MOL.0000000000000532.

PMID:
29878903
6.

Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.

Colombo M, Looker HC, Farran B, Agakov F, Brosnan MJ, Welsh P, Sattar N, Livingstone S, Durrington PN, Betteridge DJ, McKeigue PM, Colhoun HM.

Atherosclerosis. 2018 Jul;274:182-190. doi: 10.1016/j.atherosclerosis.2018.05.014. Epub 2018 May 25.

7.

Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study.

Celis-Morales CA, Lyall DM, Steell L, Gray SR, Iliodromiti S, Anderson J, Mackay DF, Welsh P, Yates T, Pell JP, Sattar N, Gill JMR.

BMC Med. 2018 May 24;16(1):77. doi: 10.1186/s12916-018-1063-1.

8.

Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants.

Celis-Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, Anderson J, Iliodromiti S, Sillars A, Graham N, Mackay DF, Pell JP, Gill JMR, Sattar N, Gray SR.

BMJ. 2018 May 8;361:k1651. doi: 10.1136/bmj.k1651.

9.

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.

PMID:
29728717
10.

The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent.

Iliodromiti S, Celis-Morales CA, Lyall DM, Anderson J, Gray SR, Mackay DF, Nelson SM, Welsh P, Pell JP, Gill JMR, Sattar N.

Eur Heart J. 2018 May 1;39(17):1514-1520. doi: 10.1093/eurheartj/ehy057.

11.

Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.

Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, Lyall DM, Iliodromiti S, Gill JMR, Pell J, Jhund PS, Sattar N.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1415-1423. doi: 10.1161/ATVBAHA.118.310945. Epub 2018 Apr 26.

PMID:
29699973
12.

A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease.

Bodde MC, Welsh P, Bergheanu SC, Lijfering WM, Mertens B, Liem AH, van der Laarse A, Sattar N, Jukema JW.

Clin Pharmacol Ther. 2018 Apr 19. doi: 10.1002/cpt.1095. [Epub ahead of print]

PMID:
29672821
13.

Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men.

Parsons TJ, Sartini C, Welsh P, Sattar N, Ash S, Lennon LT, Wannamethee SG, Lee IM, Whincup PH, Jefferis BJ.

Int J Cardiol. 2018 Mar 1;254:322-327. doi: 10.1016/j.ijcard.2017.11.003. Epub 2018 Jan 28.

14.

Correlating Changes in Metabolic Status With Arterial Health: Modest Associations but Any Clinical Implications?

Welsh P.

Hypertension. 2018 Feb;71(2):227-228. doi: 10.1161/HYPERTENSIONAHA.117.10595. Epub 2017 Dec 26. No abstract available.

PMID:
29279313
15.

Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment-Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications.

Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C.

Circ Cardiovasc Imaging. 2017 Dec;10(12). pii: e006586. doi: 10.1161/CIRCIMAGING.117.006586.

16.

The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation.

Stoumpos S, Lees J, Welsh P, Hund M, Geddes CC, Nelson SM, Mark PB.

Reprod Biomed Online. 2018 Feb;36(2):219-226. doi: 10.1016/j.rbmo.2017.11.003. Epub 2017 Nov 28.

PMID:
29233504
17.

Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.

Delles C, Rankin NJ, Boachie C, McConnachie A, Ford I, Kangas A, Soininen P, Trompet S, Mooijaart SP, Jukema JW, Zannad F, Ala-Korpela M, Salomaa V, Havulinna AS, Welsh P, Würtz P, Sattar N.

Eur J Heart Fail. 2018 Apr;20(4):663-673. doi: 10.1002/ejhf.1076. Epub 2017 Dec 11.

18.

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R.

Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.

PMID:
29221645
19.

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.

Taylor R, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Sattar N, Welsh P, Peters C, Zhyzhneuskaya S, Hollingsworth KG, Al-Mrabeh A, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Kean S, Ford I, McConnachie A, Lean MEJ.

Diabetologia. 2018 Mar;61(3):589-598. doi: 10.1007/s00125-017-4503-0. Epub 2017 Nov 30.

PMID:
29188339
20.

Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 years.

Botha S, Forde L, MacNaughton S, Shearer R, Lindsay R, Sattar N, Morrison D, Welsh P, Logue J.

Diabetes Obes Metab. 2018 Apr;20(4):879-888. doi: 10.1111/dom.13171. Epub 2018 Jan 11.

PMID:
29178635
21.

Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes.

Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C.

JACC Cardiovasc Imaging. 2017 Nov 10. pii: S1936-878X(17)30916-6. doi: 10.1016/j.jcmg.2017.08.027. [Epub ahead of print]

22.

Cord Metabolic Profiles in Obese Pregnant Women: Insights Into Offspring Growth and Body Composition.

Patel N, Hellmuth C, Uhl O, Godfrey K, Briley A, Welsh P, Pasupathy D, Seed PT, Koletzko B, Poston L; UPBEAT Consortium.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):346-355. doi: 10.1210/jc.2017-00876.

23.

Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study.

Sartini C, Whincup PH, Wannamethee SG, Jefferis BJ, Lennon L, Lowe GD, Welsh P, Sattar N, Morris RW.

BMJ Open. 2017 Nov 12;7(11):e018264. doi: 10.1136/bmjopen-2017-018264.

24.

Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study.

Vieira MC, White SL, Patel N, Seed PT, Briley AL, Sandall J, Welsh P, Sattar N, Nelson SM, Lawlor DA, Poston L, Pasupathy D; UPBEAT Consortium.

BMC Med. 2017 Nov 3;15(1):194. doi: 10.1186/s12916-017-0956-8.

25.

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.

Rutherford E, Mangion K, McComb C, Bell E, Cockburn S, Talle M, Roditi G, Welsh P, Woodward R, Radjenovic A, Struthers AD, Jardine AG, Berry C, Patel RK, Mark PB.

Sci Rep. 2017 Oct 25;7(1):13976. doi: 10.1038/s41598-017-14481-y.

26.

Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study.

Celis-Morales CA, Petermann F, Hui L, Lyall DM, Iliodromiti S, McLaren J, Anderson J, Welsh P, Mackay DF, Pell JP, Sattar N, Gill JMR, Gray SR.

Diabetes Care. 2017 Dec;40(12):1710-1718. doi: 10.2337/dc17-0921. Epub 2017 Oct 6.

PMID:
28986505
27.

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.

Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV.

Eur J Heart Fail. 2018 Feb;20(2):268-277. doi: 10.1002/ejhf.988. Epub 2017 Sep 27.

PMID:
28960777
28.

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.

Price AH, Weir CJ, Welsh P, McLachlan S, Strachan MWJ, Sattar N, Price JF.

Atherosclerosis. 2017 Sep;264:67-73. doi: 10.1016/j.atherosclerosis.2017.07.009. Epub 2017 Jul 12.

29.

Metabolic profiling of gestational diabetes in obese women during pregnancy.

White SL, Pasupathy D, Sattar N, Nelson SM, Lawlor DA, Briley AL, Seed PT, Welsh P, Poston L; UPBEAT Consortium.

Diabetologia. 2017 Oct;60(10):1903-1912. doi: 10.1007/s00125-017-4380-6. Epub 2017 Aug 1.

PMID:
28766127
30.

Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.

Wannamethee SG, Welsh P, Papacosta O, Ellins EA, Halcox JPJ, Whincup PH, Sattar N.

Atherosclerosis. 2017 Sep;264:36-43. doi: 10.1016/j.atherosclerosis.2017.07.008. Epub 2017 Jul 12.

31.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.

Willeit P, Welsh P, Evans JDW, Tschiderer L, Boachie C, Jukema JW, Ford I, Trompet S, Stott DJ, Kearney PM, Mooijaart SP, Kiechl S, Di Angelantonio E, Sattar N.

J Am Coll Cardiol. 2017 Aug 1;70(5):558-568. doi: 10.1016/j.jacc.2017.05.062. Review.

32.

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.

Ohkuma T, Jun M, Woodward M, Zoungas S, Cooper ME, Grobbee DE, Hamet P, Mancia G, Williams B, Welsh P, Sattar N, Shaw JE, Rahimi K, Chalmers J; ADVANCE Collaborative Group.

Diabetes Care. 2017 Sep;40(9):1203-1209. doi: 10.2337/dc17-0509. Epub 2017 Jul 6.

33.

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Jenks SJ, Conway BR, McLachlan S, Teoh WL, Williamson RM, Webb DJ, Welsh P, Sattar N, Strachan MWJ, Price JF.

Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.

34.

Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study.

Celis-Morales CA, Lyall DM, Welsh P, Anderson J, Steell L, Guo Y, Maldonado R, Mackay DF, Pell JP, Sattar N, Gill JMR.

BMJ. 2017 Apr 19;357:j1456. doi: 10.1136/bmj.j1456.

35.

Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?

Welsh P, Grassia G, Botha S, Sattar N, Maffia P.

Br J Pharmacol. 2017 Nov;174(22):3898-3913. doi: 10.1111/bph.13818. Epub 2017 Jun 10. Review.

36.

Physical Activity, Sedentary Behavior, and Inflammatory and Hemostatic Markers in Men.

Parsons TJ, Sartini C, Welsh P, Sattar N, Ash S, Lennon LT, Wannamethee SG, Lee IM, Whincup PH, Jefferis BJ.

Med Sci Sports Exerc. 2017 Mar;49(3):459-465. doi: 10.1249/MSS.0000000000001113.

37.

Thyroid stimulating hormone (TSH) ≥2.5mU/l in early pregnancy: Prevalence and subsequent outcomes.

Carty DM, Doogan F, Welsh P, Dominiczak AF, Delles C.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:366-369. doi: 10.1016/j.ejogrb.2017.01.048. Epub 2017 Jan 25.

PMID:
28153744
38.

Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention.

White SL, Lawlor DA, Briley AL, Godfrey KM, Nelson SM, Oteng-Ntim E, Robson SC, Sattar N, Seed PT, Vieira MC, Welsh P, Whitworth M, Poston L, Pasupathy D; UPBEAT Consortium.

PLoS One. 2016 Dec 8;11(12):e0167846. doi: 10.1371/journal.pone.0167846. eCollection 2016.

39.

Relationship between outdoor temperature and cardiovascular disease risk factors in older people.

Sartini C, Barry SJ, Whincup PH, Wannamethee SG, Lowe GD, Jefferis BJ, Lennon L, Welsh P, Ford I, Sattar N, Morris RW.

Eur J Prev Cardiol. 2017 Mar;24(4):349-356. doi: 10.1177/2047487316682119. Epub 2016 Dec 5.

40.

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

Preiss D, Dawed A, Welsh P, Heggie A, Jones AG, Dekker J, Koivula R, Hansen TH, Stewart C, Holman RR, Franks PW, Walker M, Pearson ER, Sattar N; DIRECT consortium group.

Diabetes Obes Metab. 2017 Mar;19(3):356-363. doi: 10.1111/dom.12826. Epub 2016 Dec 28.

41.

Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.

Rankin NJ, Preiss D, Welsh P, Sattar N.

Int J Epidemiol. 2016 Oct;45(5):1351-1371. Epub 2016 Oct 27. Review.

42.

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.

Welsh P, Tuckwell K, McInnes IB, Sattar N.

Atherosclerosis. 2016 Nov;254:167-171. doi: 10.1016/j.atherosclerosis.2016.10.016. Epub 2016 Oct 8.

43.

Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction.

Carrick D, Haig C, Carberry J, May VT, McCartney P, Welsh P, Ahmed N, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Mahrous A, Rauhalammi SM, Mordi I, Ford I, Radjenovic A, Sattar N, Oldroyd KG, Berry C.

JCI Insight. 2016 May 5;1(6):e85768.

44.

Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.

Natriuretic Peptides Studies Collaboration, Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, Kee F, Ärnlöv J, Salomaa V, Levy D, Kauhanen J, Laukkanen JA, Kavousi M, Ninomiya T, Casas JP, Daniels LB, Lind L, Kistorp CN, Rosenberg J, Mueller T, Rubattu S, Panagiotakos DB, Franco OH, de Lemos JA, Luchner A, Kizer JR, Kiechl S, Salonen JT, Goya Wannamethee S, de Boer RA, Nordestgaard BG, Andersson J, Jørgensen T, Melander O, Ballantyne ChM, DeFilippi Ch, Ridker PM, Cushman M, Rosamond WD, Thompson SG, Gudnason V, Sattar N, Danesh J, Di Angelantonio E.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):840-9. doi: 10.1016/S2213-8587(16)30196-6. Epub 2016 Sep 3.

45.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014. Epub 2016 Aug 5.

46.

Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction.

Carberry J, Carrick D, Haig C, Rauhalammi SM, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C.

Hypertension. 2016 Aug;68(2):385-91. doi: 10.1161/HYPERTENSIONAHA.116.07222. Epub 2016 Jun 27.

47.

High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.

Khamis RY, Hughes AD, Caga-Anan M, Chang CL, Boyle JJ, Kojima C, Welsh P, Sattar N, Johns M, Sever P, Mayet J, Haskard DO.

EBioMedicine. 2016 Jul;9:372-380. doi: 10.1016/j.ebiom.2016.06.012. Epub 2016 Jun 20.

48.

Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.

Wannamethee SG, Welsh P, Lennon L, Papacosta O, Whincup PH, Sattar N.

Diabetologia. 2016 Sep;59(9):1904-12. doi: 10.1007/s00125-016-4011-7. Epub 2016 Jun 16.

49.

Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA Trial.

Preiss D, Welsh P, Sattar N.

Diabetes Care. 2016 Aug;39(8):e114-5. doi: 10.2337/dc16-0887. Epub 2016 Jun 6. No abstract available.

PMID:
27271181
50.

Using a modified dredging elutriate testing approach to evaluate potential aquatic impacts associated with dredging a large freshwater industrial harbor.

Watson-Leung T, Graham M, Hartman E, Welsh PG.

Integr Environ Assess Manag. 2017 Jan;13(1):155-166. doi: 10.1002/ieam.1790. Epub 2016 Jul 18.

PMID:
27144596

Supplemental Content

Loading ...
Support Center